Objectives: To evaluate the efficacy of a multimodal treatment protocol—comprising microfocused ultrasound (MFU), dermal fillers, biostimulators, and botulinum toxin—in achieving comprehensive lip and perioral rejuvenation and beautification.
Introduction: Aging of the lips and perioral region is marked by the progressive loss of collagen, elastic fibers, hyaluronic acid, and subcutaneous fat. These changes diminish hydration, elasticity, and volume, leading to clinical manifestations such as perioral rhytides, lip thinning, oral commissure descent, and marionette lines. Modern beauty standards underscore the lips as a key feature of facial attractiveness, necessitating both rejuvenation and enhancement interventions.
Materials / method: A combination of microfocused ultrasound with visualization (MFU-V), hyaluronic acid dermal fillers, biostimulators (polynucleotides), and botulinum toxin was employed to target structural deficiencies of the perioral region. MFU-V was used to stimulate neocollagenesis. Dermal fillers restored volume, corrected asymmetries, and enhanced lip borders. Biostimulator promoted long-term collagen regeneration, while botulinum toxin addressed dynamic perioral lines. Representative clinical cases were analyzed to illustrate treatment outcomes.
Results: The multimodal approach resulted in significant improvement in perioral aging signs, including smoother perioral rhytides, restored lip volume, corrected asymmetries, elevated oral commissures, and softened marionette folds. Aesthetic enhancements produced fuller, more balanced, and well-defined lips, aligning with contemporary beauty ideals. Patient satisfaction was high, and treatments were well tolerated without major adverse events.
Conclusion: A multimodal strategy integrating MFU, dermal fillers, biostimulators, and botulinum toxin is effective for both perioral rejuvenation and aesthetic enhancement. This approach not only reverses signs of aging but also enhances lip morphology for improved facial attractiveness. These findings support the adoption of comprehensive treatment protocols tailored to individual patient needs.
利益冲突声明
您有否接受任何资金来支持研究这个主题?
否
您是否接受过关于这项研究的任何酬金或其他报酬?
否
你是否和任何与您的研究所涉及的药物,材料或工具有密切联系的实体存在财务关系?
否
你是否拥有或者您已经为您此研究中的工具,药物或材料申请任何专利?
否
这项工作没有任何直接或间接的资金支持。由作者自己承担责任。